Is C77.0 a billable ICD-10-CM code?

Yes. C77.0 is a billable, specific ICD-10-CM code and is valid for submission on a claim.

Where does C77.0 sit in the tabular list?

Neoplasms (C00-D49), in the block Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80).

C77.0

C77.0 — Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck

Billable / specific codeICD-10-CM

C77.0 is a billable, specific ICD-10-CM code for secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck. It is valid for submission on a claim.

Inclusion terms

Alternative wordings a physician may use in the chart for this same code.

Secondary and unspecified malignant neoplasm of supraclavicular lymph nodes

Risk adjustment

C77.0 risk-adjusts. Under the CMS-HCC V28 model it maps to this category:

HCC 18 Cancer Metastatic to Bone, Other and Unspecified Metastatic Cancer; Acute Leukemia Except Myeloid2.341 RAF

Coefficient shown for the Community Non-dual Aged segment. A higher HCC in the same hierarchy will suppress this one, so capturing it does not always add score.

Medicare coverage

C77.0 is named in 43 Medicare coverage policies — 43 listing it as supporting medical necessity. Which of them applies to you depends on your Medicare contractor, and coverage genuinely differs by state.

A52479Oral Anticancer Drugs - Policy Article
A52480Oral Antiemetic Drugs (Replacement for Intravenous Antiemetics) - Policy Article
A52986Billing and Coding: Biomarkers for Oncology
A53101Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update

Related codes at this level

Codes that share C77. If C77.0 is not quite right, the correct code is usually one of these.

Questions about C77.0

Is C77.0 a billable ICD-10-CM code?: Yes. C77.0 is a billable, specific ICD-10-CM code and is valid for submission on a claim.
Where does C77.0 sit in the tabular list?: Neoplasms (C00-D49), in the block Malignant neoplasms of ill-defined, other secondary and unspecified sites (C76-C80).